Active, not recruiting
Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
NCT06637150
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- breast cancer institute of Fudan University Cancer Hospital, shanghai, shanghai Shanghai, China